The Efficacy of Reiki in the Treatment of Fibromyalgia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00051428 |
Recruitment Status :
Completed
First Posted : January 15, 2003
Last Update Posted : August 18, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Fibromyalgia | Procedure: Reiki (distant and direct-contact) | Phase 1 |
Fibromyalgia is one of the most common rheumatologic diagnoses. Treatment is generally unsatisfactory and most randomized, controlled treatment trials have been unable to demonstrate a sustained effective intervention. A vast body of anecdotal literature as well as two randomized controlled trials suggest that Reiki may be an effective treatment for FM, appearing to relieve pain and improve psychological well being. Reiki appears to have no adverse effects and can eventually be self-administered, making it a low-risk, low-cost, potentially patient-empowering intervention. This study will investigate the efficacy of Reiki in the treatment of FM.
One hundred Reiki-naive FM patients will be recruited from a chronic fatigue referral clinic and will participate in an 8-week trial. Patients will be randomized into one of two Reiki groups (direct-contact and distant Reiki) or one of two control groups (sham and placebo). Patients will receive either Reiki or placebo 16 times during the course of the study. Patients will be assessed at study entry, at Weeks 4 and 8, and 12 weeks post-treatment.
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | The Efficacy of Reiki in the Treatment of Fibromyalgia |
Study Start Date : | January 2003 |
Study Completion Date : | February 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
- Fibromyalgia without concurrent medical conditions associated with chronic pain, such as diabetic neuropathy, systemic lupus erythematosus, or severe degenerative joint disease
- Willing to undergo randomization and attend treatments regularly
- Willing to stay on a stable medical regimen during the entire 8-week trial and use only acetaminophen for breakthrough pain
- Live within a one-hour drive of the study site
Exclusion Criteria
- Received Reiki or any other energy medicine (Therapeutic Touch, Qi Gong, SHEN Therapy, etc.)
- Pregnant
- Pending litigation or disability claim related to FM

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00051428
United States, Washington | |
Univ of WA - CFS/FM Research Center | |
Seattle, Washington, United States, 98104 |
Principal Investigator: | Dedra S. Buchwald | University of Washington |
ClinicalTrials.gov Identifier: | NCT00051428 |
Other Study ID Numbers: |
R21AT001075-01 ( U.S. NIH Grant/Contract ) |
First Posted: | January 15, 2003 Key Record Dates |
Last Update Posted: | August 18, 2006 |
Last Verified: | August 2006 |
Fibromyalgia, Reiki, Energy Medicine |
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |